Resveratrol bioavailability and toxicity in humans

Molecular Nutrition and Food Research

Volumn 54, Issue 1, 2010, Pages 7-16

  Cottart, Charles Henry ^a,b   Nivet Antoine, Valérie ^a,b   Laguillier Morizot, Christelle ^a   Beaudeux, Jean Louis ^a,b  

^a HÔPITAL CHARLES FOIX   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bioavailability; Humans; Metabolites; Resveratrol; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; BIOAVAILABILITY; BIOTRANSFORMATION; HUMAN; METABOLISM; PHYTOTHERAPY; REVIEW; TOXICITY TESTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; HUMANS; PHYTOTHERAPY; STILBENES; TOXICITY TESTS;

EID: 74349100733     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900437     Document Type: Review

References (55)

1. Siemann, E. H., Creasy, L. L., Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 1992, 43, 49-52.
2. Constant, J., Alcohol, ischemic heart disease, and the French paradox. Coron. Artery Dis. 1997, 8, 645-649.
3. Renaud, S. C., Gueguen, R., Schenker, J., d'Houtaud, A., Alcohol and mortality in middle-aged men from eastern France. Epidemiology 1998, 9, 184-188.
4. Kundu, J. K., Surh, Y.-J., Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269, 243-261.
5. Bishayee, A., Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. (Phila Pa) 2009, 2, 409-418.
6. Wolter, F., Ulrich, S., Stein, J., Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? J. Nutr. 2004, 134, 3219-3222.
7. Marambaud, P., Zhao, H., Davies, P., Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 2005, 280, 37377-37382.
8. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A. et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
9. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W. et al., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425, 191-196.
10. Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C. et al., Bioavailability of trans-resveratrol from red wine in humans. Mol. Nutr. Food Res. 2005, 49, 495-504.
11. Ribeiro de Lima, M. T., Waffo-Teguo, P., Teissedre, P. L., Pujolas, A. et al., Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J. Agric. Food Chem. 1999, 47, 2666-2670.
12. Wang, Y., Catana, F., Yang, Y., Roderick, R., van Breemen, R. B., An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J. Agric. Food Chem. 2002, 50, 431-435.
13. Moreno-Labanda, J. F., Mallavia, R., Perez-Fons, L., Lizama, V. et al., Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety. J. Agric. Food Chem. 2004, 52, 5396-5403.
14. Lamuela-Raventos, R. M., Romero-Perez, A. I., Waterhouse, A. L., De La Torre-Boronat, M. C., Direct HPLC analysis of cis-resveratrol and trans-resveratrol and piceid isomers in spanish red vitis-vinifera wines. J. Agric. Food Chem. 1995, 43, 281-283.
15. Burkon, A., Somoza, V., Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma. Mol. Nutr. Food Res. 2008, 52, 549-557.
16. Romero-Perez, A. I., Ibern-Gomez, M., Lamuela-Raventos, R. M., de La Torre-Boronat, M. C., Piceid, the major resveratrol derivative in grape juices. J. Agric. Food Chem. 1999, 47, 1533-1536.
17. Urpi-Sarda, M., Jauregui, O., Lamuela-Raventos, R. M., Jaeger, W. et al., Uptake of diet resveratrol into the human low-density lipoprotein Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal. Chem. 2005, 77, 3149-3155.
18. Urpi-Sarda, M., Zamora-Ros, R., Lamuela-Raventos, R., Cherubini, A. et al., HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin. Chem. 2007, 53, 292-299.
19. Zamora-Ros, R., Urpi-Sarda, M., Lamuela-Raventos, R. M., Estruch, R. et al., Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin. Chem. 2006, 52, 1373-1380.
20. Zamora-Ros, R., Urpi-Sarda, M., Lamuela-Raventos, R. M., Estruch, R. et al., Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: The PREDIMED Study. Free Radic. Biol. Med. 2009, 46, 1562-1566.
21. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., Walle, U. K., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
22. Soleas, G. J., Yan, J., Goldberg, D. M., Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol. 2001, 335, 130-145.
23. Soleas, G. J., Yan, J., Goldberg, D. M., Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J. Chromatogr. B Biomed. Sci. Appl. 2001, 757, 161-172.
24. Goldberg, D. M., Yan, J., Soleas, G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36, 79-87.
25. Meng, X., Maliakal, P., Lu, H., Lee, M. J., Yang, C. S., Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 2004, 52, 935-942.
26. Boocock, D. J., Patel, K. R., Faust, G. E., Normolle, D. P. et al., Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848, 182-187.
27. Boocock, D. J., Faust, G. E., Patel, K. R., Schinas, A. M. et al., Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1246-1252.
28. Vaz-da-Silva, M., Loureiro, A. I., Falcao, A., Nunes, T. et al., Effect of food on the pharmacokinetic profile of trans-resveratrol. Int. J. Clin. Pharmacol. Ther. 2008, 46, 564-570.
29. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E. et al., Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol. Nutr. Food Res. 2009, 53, S7-S15.
30. Wang, L. X., Heredia, A., Song, H., Zhang, Z. et al., Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J. Pharm. Sci. 2004, 93, 2448-2457.
31. Wenzel, E., Soldo, T., Erbersdobler, H., Somoza, V., Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 2005, 49, 482-494.
32. Camont, L., Cottart, C., Rhayem, Y., Nivet-Antoine, V. et al., Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal. Chim. Acta 2009, 634, 121-128.
33. Marier, J. F., Vachon, P., Gritsas, A., Zhang, J. et al., Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 2002, 302, 369-373.
34. Gu, X., Chu, Q., O'Dwyer, M., Zeece, M., Analysis of resveratrol in wine by capillary electrophoresis. J. Chromatogr. A 2000, 881, 471-481.
35. Crowell, J. A., Korytko, P. J., Morrissey, R. L., Booth, T. D., Levine, B. S., Resveratrol-associated renal toxicity. Toxicol. Sci. 2004, 82, 614-619.
36. Juan, M. E., Vinardell, M. P., Planas, J. M., The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 2002, 132, 257-260.
37. Williams, L. D., Burdock, G. A., Edwards, J. A., Beck, M., Bausch, J., Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem. Toxicol. 2009, 47, 2170-2182.
38. Wenzel, E., Somoza, V., Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 2005, 49, 472-481.
39. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S. et al., Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003, 72, 2219-2233.
40. Abd El-Mohsen, M., Bayele, H., Kuhnle, G., Gibson, G. et al., Distribution of [3 H]trans-resveratrol in rat tissues following oral administration. Br. J. Nutr. 2006, 96, 62-70.
41. van de Wetering, K., Burkon, A., Feddema, W., Bot, A. et al., Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol. Pharmacol. 2009, 75, 876-885.
42. Yoshizumi, M., Tsuchiya, K., Suzaki, Y., Kirima, K. et al., Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 2002, 293, 1458-1465.
43. Morand, C., Crespy, V., Manach, C., Besson, C. et al., Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 1998, 275, R212-R219.
44. Manach, C., Regerat, F., Texier, O., Agullo, G. et al., Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr. Res. 1996, 16, 517-544.
45. Shimoi, K., Saka, N., Nozawa, R., Sato, M. et al., Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab. Dispos. 2001, 29, 1521-1524.
46. Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J. et al., The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 2002, 86, 774-778.
47. Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R. et al., Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 2003, 46, 3546-3554.
48. de Medina, P., Casper, R., Savouret, J. F., Poirot, M., Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J. Med. Chem. 2005, 48, 287-291.
49. Ulrich, S., Wolter, F., Stein, J. M., Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol. Nutr. Food Res. 2005, 49, 452-461.
50. Ovesna, Z., Horvathova-Kozics, K., Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 2005, 52, 450-455.
51. Juan, M. E., Maijo, M., Planas, J. M., Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed. Anal. 2009, 132, 257-260.
52. Jang, M. H., Piao, X. L., Kim, H. Y., Cho, E. J. et al., Resveratrol oligomers from Vitis amurensis attenuate beta-amyloid-induced oxidative stress in PC12 cells. Biol. Pharm. Bull. 2007, 30, 1130-1134.
53. Li, L., Henry, G. E., Seeram, N. P., Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds. J. Agric. Food Chem. 2009, 57, 7282-7287.
54. Das, S., Ng, K. Y., Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. J. Pharm. Sci. 2009 in press.
55. Lu, X., Ji, C., Xu, H., Li, X. et al., Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int. J. Pharm. 2009, 375, 89-96.